EIN Presswire is now on Substack! Follow for customer spotlights, interviews, gossip and more!

EIN Presswire is now on Substack! Follow for customer spotlights, interviews, gossip and more!

World Media Directory · RSS · Email Newsletters

There were 954 press releases posted in the last 24 hours and 402,952 in the last 365 days.

Press Releases on July 5, 2024

797 Press Releases

Published on July 5, 2024 - 16:48 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Noxafil, posaconazole, decision type: PM: decision on the application ...

P/0196/2022 : EMA decision of 9 June 2022 on the acceptance of a modification of an agreed paediatric investigation plan for posaconazole (Noxafil), (EMEA-000468-PIP02-12-M07) AdoptedReference Number: EMA/273998/2022

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:48 GMT

EMEA-000551-PIP04-21-M02

P/0240/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for givinostat (EMEA-000551-PIP04-21-M02) Reference Number: EMA/264176/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:48 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Ponvory, ponesimod, decision type: PM: decision on the application for ...

P/0234/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for ponesimod (Ponvory), (EMEA-000798-PIP01-09-M04) Reference Number: EMA/235934/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

EMEA-000902-PIP01-10-M01

P/0211/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed PIP for adsorbed modified allergen extract of a mixture of 50% dermatophagoides pteronyssinus and 50% dermatophagoides farinae (EMEA-000902-PIP01-10-M01) Reference …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Kyntheum, brodalumab, decision type: PM: decision on the application ...

P/0212/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for brodalumab (Kyntheum), (EMEA-001089-PIP02-13-M04) Reference Number: EMA/236234/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

EMEA-001150-PIP02-13-M05

P/0221/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for landiolol (hydrochloride) (Rapibloc, Landiobloc, Raploc, Runrapiq), (EMEA-001150-PIP02-13-M05) Reference Number: EMA/236236/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

EMEA-001627-PIP01-14-M03

P/0203/2023 : EMA decision of 13 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for efinaconazole (EMEA- 001627-PIP01-14-M03) Reference Number: EMA/241957/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application ...

P/0202/2023 : EMA decision of 13 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for baricitinib (Olumiant), (EMEA-001220-PIP01-11-M08) Reference Number: EMA/241941/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark, decision type: PM: decision on the application ...

P/0243/2023 : EMA decision of 16 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for birch bark extract (Filsuvez), (EMEA-001299-PIP03-17-M02) Reference Number: EMA/273941/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, upadacitinib, decision type: PM: decision on the application ...

P/0237/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for upadacitinib (Rinvoq), (EMEA-001741-PIP01-14-M06) Reference Number: EMA/236245/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, decision ...

P/0242/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for bictegravir / emtricitabine / tenofovir alafenamide (Biktarvy), (EMEA-001766-PIP01-15-M05) Reference Number: EMA/250921/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Adtralza, Tralokinumab, decision type: PM: decision on the application ...

P/0186/2023 : EMA decision of 5 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for tralokinumab (Adtralza), (EMEA-001900-PIP02-17-M07) Reference Number: EMA/175833/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Ontozry, cenobamate, decision type: PM: decision on the application for ...

P/0214/2023: EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for cenobamate (Ontozry), (EMEA-002563-PIP02-19-M02) Reference Number: EMA/256562/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

EMEA-002229-PIP02-21-M01

P/0217/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for dienogest / ethinylestradiol (EMEA-002229-PIP02-21-M01) Reference Number: EMA/238158/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

EMEA-002735-PIP01-19-M01

Deferoxamine (mesylate) histidine tryptophan aspartic acid n-acetyl-histidine (monohydrate) glycine alpha-ketoglutaric acid arginine potassium chloride magnesium chloride (hexahydrate) calcium chloride (dihydrate) sodium chloride alanine 3,4-dimethoxy-N- …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

EMEA-002735-PIP03-20-M02

histidine tryptophan aspartic acid n-acetyl-histidine (monohydrate) glycine alpha-ketoglutaric acid arginine potassium chloride magnesium chloride (hexahydrate) calcium chloride (dihydrate) sodium chloride alanine 3,4-dimethoxy-N-methylbenzohydroxamic acid …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Xevudy, Sotrovimab, decision type: PM: decision on the application for ...

P/0235/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for sotrovimab (Xevudy), (EMEA-002899-PIP01-20-M02) Reference Number: EMA/236247/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

EMEA-002762-PIP02-20-M01

P/0215/2023 : EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for denecimig (EMEA- 002762-PIP02-20-M01) Reference Number: EMA/236605/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Regkirona, Regdanvimab, decision type: PM: decision on the application ...

P/0238/2023 : EMA decision of 14 June 2023on the acceptance of a modification of an agreed paediatric investigation plan for regdanvimab (Regkirona), (EMEA-002961-PIP01-21-M02) Reference Number: EMA/236249/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 5, 2024 - 16:47 GMT

Fifth EMA/HMA Big Data Stakeholder Forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 ...

In person and online participation via Webex is organised via EU associations and direct invitations to allow a broad range of stakeholders to participate. The event will also be broadcast live and registration is not required to follow the event online.

Distribution channels: Healthcare & Pharmaceuticals Industry

Previous 6 7 8 9 10 11 12 13 14 15 16 Next

Previous Day 2024 Calendar Next Day